336 related articles for article (PubMed ID: 18097025)
1. The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells.
De Trez C; Schneider K; Potter K; Droin N; Fulton J; Norris PS; Ha SW; Fu YX; Murphy T; Murphy KM; Pfeffer K; Benedict CA; Ware CF
J Immunol; 2008 Jan; 180(1):238-48. PubMed ID: 18097025
[TBL] [Abstract][Full Text] [Related]
2. The TNF receptor and Ig superfamily members form an integrated signaling circuit controlling dendritic cell homeostasis.
De Trez C; Ware CF
Cytokine Growth Factor Rev; 2008; 19(3-4):277-84. PubMed ID: 18511331
[TBL] [Abstract][Full Text] [Related]
3. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.
Steinberg MW; Cheung TC; Ware CF
Immunol Rev; 2011 Nov; 244(1):169-87. PubMed ID: 22017438
[TBL] [Abstract][Full Text] [Related]
4. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.
Ware CF
Immunol Rev; 2008 Jun; 223():186-201. PubMed ID: 18613837
[TBL] [Abstract][Full Text] [Related]
5. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
Cai G; Freeman GJ
Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells.
Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW
J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584
[TBL] [Abstract][Full Text] [Related]
7. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
[TBL] [Abstract][Full Text] [Related]
8. BTLA interaction with HVEM expressed on CD8(+) T cells promotes survival and memory generation in response to a bacterial infection.
Steinberg MW; Huang Y; Wang-Zhu Y; Ware CF; Cheroutre H; Kronenberg M
PLoS One; 2013; 8(10):e77992. PubMed ID: 24205057
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
[TBL] [Abstract][Full Text] [Related]
10. CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.
Flynn R; Hutchinson T; Murphy KM; Ware CF; Croft M; Salek-Ardakani S
PLoS One; 2013; 8(10):e77991. PubMed ID: 24205056
[TBL] [Abstract][Full Text] [Related]
11. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.
Šedý JR; Bjordahl RL; Bekiaris V; Macauley MG; Ware BC; Norris PS; Lurain NS; Benedict CA; Ware CF
J Immunol; 2013 Jul; 191(2):828-36. PubMed ID: 23761635
[TBL] [Abstract][Full Text] [Related]
12. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM
Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026
[TBL] [Abstract][Full Text] [Related]
13. The Absence of Lymphotoxin-α, a Herpesvirus Entry Mediator (HVEM) Ligand, Affects Herpes Simplex Virus 1 Infection
Wang S; Hirose S; Ghiasi H
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142672
[TBL] [Abstract][Full Text] [Related]
14. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM.
Murphy TL; Murphy KM
Annu Rev Immunol; 2010; 28():389-411. PubMed ID: 20307212
[TBL] [Abstract][Full Text] [Related]
15. Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo.
Abe K; Yarovinsky FO; Murakami T; Shakhov AN; Tumanov AV; Ito D; Drutskaya LN; Pfeffer K; Kuprash DV; Komschlies KL; Nedospasov SA
Blood; 2003 Feb; 101(4):1477-83. PubMed ID: 12560241
[TBL] [Abstract][Full Text] [Related]
16. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
[TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.
Das R; Coupar J; Clavijo PE; Saleh A; Cheng TF; Yang X; Chen J; Van Waes C; Chen Z
Mol Carcinog; 2019 Mar; 58(3):411-425. PubMed ID: 30488488
[TBL] [Abstract][Full Text] [Related]
18. Modulation of T cell proliferation through the LIGHT-HVEM-BTLA cosignaling pathway.
Cheung TC
Recent Pat DNA Gene Seq; 2009; 3(3):177-82. PubMed ID: 19702559
[TBL] [Abstract][Full Text] [Related]
19. Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor.
Taylor RT; Lügering A; Newell KA; Williams IR
J Immunol; 2004 Dec; 173(12):7183-9. PubMed ID: 15585839
[TBL] [Abstract][Full Text] [Related]
20. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.
del Rio ML; Jones ND; Buhler L; Norris P; Shintani Y; Ware CF; Rodriguez-Barbosa JI
J Immunol; 2012 May; 188(10):4885-96. PubMed ID: 22490863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
